Résumé
Les études épidémiologiques ont permis de connaïtre les sujets à risque élevé de cancer colorectal. Le niveau de risque dans certains de ces groupes justifie une stratégie de dépistage individuel, même si la relative faible prévalence de ces cas fait qu'ils ne sont à l'origine que d'un nombre modeste de cancers colorectaux. Près de 10% de la population générale et 20% des sujets atteints de cancer colorectal ont un antécédent familial de cancer colorectal. Le niveau de risque dans les groupes à risque élevé, conditionne la stratégie de dépistage à proposer à ces sujets. Chez les apparentés au 1er degré de sujets atteints d'un cancer colorectal, ce risque varie avec l'âge au diagnostic du cas index et le nombre de parents atteints. Le risque cumulé se situe entre 10 et 20% pour les individus ayant un parent au 1er degré atteint avant l'âge de 45 ans ou pour ceux ayant au moins 2 apparentés atteints: il paraît alors suffisamment élevé pour proposer une coloscopie de dépistage. Une coloscopie est également recommandée chez les sujets ayant une rectocolite hémorragique ou une maladie de Crohn étendue (pancolite) évoluant depuis plus de 15 ans et chez les sujets ayant des antécédents personnels de cancer colorectal ou d'adénome de plus de 1 cm.
Summary
Epidemiological studies enable us to find out which subjects are at high risk of colorectal cancer. The risk level amongst some of these groups justifies an individual screening strategy, even if the relatively low prevalence of these cases means that they only give rise to a limited number of colorectal cancers. A family history of colorectal cancer is found in nearly 10% of the general population and in 20% of subjects with colorectal cancer. The risk level in high risk groups determines the screening strategy to be offered to these subjects. Among first degree relatives of patients with colorectal cancer, this risk varies with age at diagnosis of the index case, and with the number of affected relatives. The cumulated lifetime risk is comprised between 10 and 25% for individuals with one relative affected before the age of 45 or for those with at least two affected relatives, which is high enough to warrant colonoscopic screening. Colonoscopy is also recommended in subjects with either a haemorrhagic rectocolitis or extended Crohn's disease (pancolitis) which has been developing for at least 15 years, and in subjects with a personal history of colorectal cancer or an adenoma larger than 1 cm.
Références
KRONBORG O., FENGER C., OLSEN J., JORGENSEN O.D., SONDERGAARD O. — Randomised study of screening for colorectal cancer with faecal-occult-blood test.Lancet, 1996,348, 1467–1471.
HARDCASTLE J.D., CHAMBERLAIN J.O., ROBINSON M.H.et al. — Randomised controlled trial of faecal-occult-blood screening for colorectal cancer [see comments].Lancet, 1996,348, 1472–1477.
FAIVRE J., TAZI M., EL MRINI T., LEJEUNE C., BENHAMICHE A., DASSONVILLE F. — Faecal occult blood screening and reduction of colorectal cancer mortality. A case-control study.Brit. J. Cancer, 1998,79, 680–683.
BENHAMICHE-BOUVIER A.M., LEJEUNE C., JOUVE J.L., MANFREDI S., BONITHON-KOPP C., FAIVRE J. — Family history and risk of colorectal cancer: implications for screening programmes.J. Med. Screen., 2000,7, 136–140.
NEGRI E., BRAGA C., LA VECCHIA C.et al. — Family history of cancer and risk of colorectal cancer in Italy.Br. J. Cancer, 1998,77, 174–179.
FUCHS C., GIOVANNUCCI E., COLDITZ G., HUNTER D., SPEIZER F., WILLETT W. — A prospective study of family history and the risk of colorectal cancer.N. Engl. J. Med., 1994,331, 1669–1694.
St JOHN D., DERMOTT F.M., HOPPER J., DEBNEY E., JOHNSON W., HUGHES S. — Cancer risk in relatives of patients with common colorectal cancer.Ann. Intern. Med., 1993,118, 785–790.
SANDHU M.S., LUBEN R., KHAW K.T. — Prevalence and family history of colorectal cancer: implications for screening.J. Med. Screen., 2001,8, 69–72.
WINAWER S.J., FLETCHER R.H., MILLER L.et al. — Colorectal cancer screening: clinical guidelines and rationale.Gastroenterology, 1997,112, 594–642.
PARIENTE A., MILAN C., LAFON J., FAIVRE J. — Colonoscopic screening in first-degree relatives of patients with ‘sporadic’ colorectal cancer: a case-control study. Association Nationale des Gastroentérologues des Hopitaux et Registre Bourguignon des Cancers Digestifs (INSERM CRI 9505).Gastroenterology, 1998,115, 7–12.
GUILLEM J.G., FORDE K.A., TREAT M.R., NEUGUT A.I., O'TOOLE K.M., DIAMOND B.E. — Colonoscopic screening for neoplasms in asymptomatic first-degree relatives of colon cancer patients. A controlled, prospective study.Dis. Colon. Rectum, 1992,35, 523–529.
Conférence de Consensus. Prévention, dépistage et prise en charge des cancers du côlon. 1998,22, S275–288.
WINAWER S., ZAUBER A., GERDES H.et al. — Risk of coloretcal cancer in the families of patients with adenomatous polyps.N. Engl. J. Med., 1996,334, 82–87.
BOUTRON M., FAIVRE J., QUIPOURT V., SENESSE P., MICHIELS C. — Family history of colorectal tumours and implications for the adenoma-carcinoma sequence: a case control study.Gut, 1995,37, 830–834.
ATKIN W., MORSON B., CUZICK J. — Long-term risk of colorectal cancer after excision of rectosigmoid adenomas.N. Engl. J. Med., 1992,326, 658–662.
THIIX-EVENSEN E., HOFF G.S., SAUAR J., LANGMARK F., MAJAK B.M., VATN M.H. — Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Telemark Polyp Study.Scand. J. Gastroenterol., 1999,34, 414–420.
CALI R.L., PITSCH R.M., THORSON A.G.et al. — Cumulative incidence of metachronous colorectal cancer.Dis. Colon. Rectum, 1993,36, 388–393.
HOAR S.K., WILSON J., BLOT W.J., McLAUGHLIN J.K., WINN D.M., KANTOR A.F. — Second cancer following cancer of the digestive system in Connecticut, 1935–82.Natl. Cancer Inst. Monogr., 1985,68, 49–82.
EKBOM A., HELMICK C., ZACK M., ADAMI H. — Ulcerative colitis and colorectal cancer. A population-based study.N. Engl. J. Med., 1990,18, 1228–1233.
EKBOM A., HELMICK C., ZACK M., ADAMI H. — Increased risk of large-bowel cancer in Crohn's disease with colonic involvement.Lancet, 1990,336, 357–359.
GILLEN C., ANDREWS H., PRIOR P., ALLAN R. — Crohn's disease and colorectal cancer.Gut, 1994,35, 651–655.
SCHOEN R., WEISSFELD J., HUTLER L. — Are women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer?Am. J. Gastroenterol., 1994,89, 835–842.
HARVEY E.B., BRINTON L.A. — Second cancer following cancer of the breast in Connecticut, 1935–82.Natl. Cancer. Inst. Monogr., 1985,68, 99–112.
GIOVANNUCCI E., COLDITZ G., STAMPFER M. — A meta-analysis of cholecystectomy and risk of colorectal cancer.Gastroenterology, 1993,105, 130–141.
EKBOM A., YUEN J., ADAMI H., McLAUGHLIN J., CHOW W., PERSON I. — Cholecystectomy and colorectal cancer.Gastroenterology, 1993,105, 142–147.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Bouvier, AM., Faivre, J. & Lejeune, C. Stratégie de dépistage des cancers colorectaux chez les sujets à risque élevé. Acta Endosc 32, 623–631 (2002). https://doi.org/10.1007/BF03018871
Issue Date:
DOI: https://doi.org/10.1007/BF03018871